These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10349 related articles for article (PubMed ID: 1760821)

  • 1. Regression of human melanoma xenografts in nude mice injected with methotrexate linked to monoclonal antibody 225.28 to human high molecular weight-melanoma associated antigen.
    Ghose T; Ferrone S; Blair AH; Kralovec Y; Temponi M; Singh M; Mammen M
    Cancer Immunol Immunother; 1991; 34(2):90-6. PubMed ID: 1760821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human renal cancer by monoclonal antibody targeted methotrexate-containing liposomes in an ascites tumor model.
    Singh M; Ghose T; Mezei M; Belitsky P
    Cancer Lett; 1991 Feb; 56(2):97-102. PubMed ID: 1998948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of methotrexate-containing liposomes with a monoclonal antibody against human renal cancer.
    Singh M; Ghose T; Faulkner G; Kralovec J; Mezei M
    Cancer Res; 1989 Jul; 49(14):3976-84. PubMed ID: 2660984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human high molecular weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody MK2-23. Characterization of the immunogenicity in syngeneic hosts.
    Chen ZJ; Yang H; Ferrone S
    J Immunol; 1991 Aug; 147(3):1082-90. PubMed ID: 1861071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiotypic cascade in the human high molecular weight melanoma-associated antigen system: fine specificity and idiotypic profile of anti-anti-idiotypic monoclonal antibodies.
    Yang H; Chen ZJ; Kageshita T; Yamada M; Ferrone S
    Eur J Immunol; 1993 Jul; 23(7):1671-7. PubMed ID: 7686858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
    Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF
    Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma.
    Mittelman A; Chen ZJ; Yang H; Wong GY; Ferrone S
    Proc Natl Acad Sci U S A; 1992 Jan; 89(2):466-70. PubMed ID: 1731316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human high molecular weight-melanoma associated antigen mimicry by an anti-idiotypic antibody: characterization of the immunogenicity and the immune response to the mouse monoclonal antibody IMel-1.
    Chattopadhyay P; Kaveri SV; Byars N; Starkey J; Ferrone S; Raychaudhuri S
    Cancer Res; 1991 Nov; 51(22):6045-51. PubMed ID: 1933867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
    Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
    Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between induction of anti high molecular weight-melanoma associated antigen (HMW-MAA) immunity with mouse antiidiotypic monoclonal antibody (MoAb) MK2-23 and prolongation of survival in patients with melanoma.
    Chen ZJ; Yang H; Liu CC; Mittelman A; Ferrone S
    Pigment Cell Res; 1992; Suppl 2():113-22. PubMed ID: 1409413
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulation by adjuvants and carriers of the immunogenicity in xenogeneic hosts of mouse anti-idiotypic monoclonal antibody MK2-23, an internal image of human high molecular weight-melanoma associated antigen.
    Chen ZJ; Yang H; Liu CC; Hirai S; Ferrone S
    Cancer Res; 1993 Jan; 53(1):112-9. PubMed ID: 8416734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human high-molecular-weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody TK7-371.
    Chen ZJ; Yang H; Kageshita T; Ferrone S
    Cancer Res; 1991 Sep; 51(18):4790-7. PubMed ID: 1716513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of human melanoma growth in nude mice injected with anti high-molecular-weight melanoma-associated antigen monoclonal antibody 225.28S conjugated to purothionin.
    Matsui M; Nakanishi T; Noguchi T; Imai K; Yachi A; Ferrone S
    Jpn J Cancer Res; 1985 Feb; 76(2):119-23. PubMed ID: 3920101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody.
    Hafner C; Breiteneder H; Ferrone S; Thallinger C; Wagner S; Schmidt WM; Jasinska J; Kundi M; Wolff K; Zielinski CC; Scheiner O; Wiedermann U; Pehamberger H
    Int J Cancer; 2005 Apr; 114(3):426-32. PubMed ID: 15578703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal antibody MK2-23 by fusion with interleukin 2.
    Wang X; Ko EC; Peng L; Gillies SD; Ferrone S
    Cancer Res; 2005 Aug; 65(15):6976-83. PubMed ID: 16061683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
    Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
    Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen.
    Fawwaz RA; Wang TS; Estabrook A; Rosen JM; Hardy MA; Alderson PO; Srivastava SC; Richards P; Ferrone S
    J Nucl Med; 1985 May; 26(5):488-92. PubMed ID: 3989605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodies.
    Drake AS; Brady MT; Wang XH; Sait SJ; Earp JC; Ghoshal Gupta S; Ferrone S; Wang ES; Wetzler M
    Cancer Immunol Immunother; 2009 Mar; 58(3):415-27. PubMed ID: 18677475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phage-selected primate antibodies fused to superantigens for immunotherapy of malignant melanoma.
    Tordsson JM; Ohlsson LG; Abrahmsén LB; Karlström PJ; Lando PA; Brodin TN
    Cancer Immunol Immunother; 2000 Mar; 48(12):691-702. PubMed ID: 10752477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels.
    Shockley TR; Lin K; Sung C; Nagy JA; Tompkins RG; Dedrick RL; Dvorak HF; Yarmush ML
    Cancer Res; 1992 Jan; 52(2):357-66. PubMed ID: 1728407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 518.